| Analysis and correction of crosstalk effects in pathway analysis M Donato, Z Xu, A Tomoiaga, JG Granneman, RG MacKenzie, R Bao, ... Genome research 23 (11), 1885-1893, 2013 | 152 | 2013 |
| Ssd1 and Gcn2 suppress global translation efficiency in replicatively aged yeast while their activation extends lifespan Z Hu, B Xia, SDL Postnikoff, ZJ Shen, AS Tomoiaga, TA Harkness, ... Elife 7, e35551, 2018 | 69 | 2018 |
| Machine learning uncovers cell identity regulator by histone code B Xia, D Zhao, G Wang, M Zhang, J Lv, AS Tomoiaga, Y Li, X Wang, ... Nature communications 11 (1), 2696, 2020 | 28 | 2020 |
| Clinical trials simulation: a statistical approach PH Westfall, K Tsai, S Ogenstad, A Tomoiaga, S Moseley, Y Lu Journal of Biopharmaceutical Statistics 18 (4), 611-630, 2008 | 20 | 2008 |
| Broad genic repression domains signify enhanced silencing of oncogenes D Zhao, L Zhang, M Zhang, B Xia, J Lv, X Gao, G Wang, Q Meng, Y Yi, ... Nature communications 11 (1), 5560, 2020 | 11 | 2020 |
| Discovery of novel determinants of endothelial lineage using chimeric heterokaryons WT Wong, G Matrone, XY Tian, SA Tomoiaga, KF Au, S Meng, ... Elife 6, e23588, 2017 | 9 | 2017 |
| Pathway crosstalk effects: shrinkage and disentanglement using a Bayesian hierarchical model A Tomoiaga, P Westfall, M Donato, S Draghici, S Hassan, R Romero, ... Statistics in biosciences 8, 374-394, 2016 | 7 | 2016 |
| Case study on renewable energy in New York: bridging the gap between promise and reality AS Tomoiaga, S Ammar, C Freund International Journal of Energy Sector Management 15 (1), 21-35, 2021 | 5 | 2021 |
| A method for analysis and correction of cross-talk effects in pathway analysis M Donato, S Draghici, A Tomoiaga, P Westfall, Z Xu, R Romero The 2012 International Joint Conference on Neural Networks (IJCNN), 1-7, 2012 | 5 | 2012 |
| A transcriptomic classifier model identifies high-risk endotypes in a prospective study of sepsis in Uganda MJMD Cummings, BM Bakamutumaho, ASPD Tomoiaga, NBA Owor, ... Clinical care medicine, 2023 | 2 | 2023 |
| Clinical trials simulation: A publicly available, grid-enabled, GUI-Driven SAS® System PH Westfall, A Dmitrienko, C DeSouza, A Tomoiaga SAS Global Forum, 2010 | 2 | 2010 |
| An Idealet-Centric Scheme for Large Scale Open Innovation Systems M Hämäläinen, Q Li, Z Lin, A Tomoiaga, J Wang Exploring the Grand Challenges for Next Generation E-Business: 8th Workshop …, 2011 | 1 | 2011 |
| COVID-19 immune signatures in Uganda persist in HIV co-infection and diverge by pandemic phase MJ Cummings, B Bakamutumaho, JJ Lutwama, N Owor, X Che, ... Nature Communications 15 (1), 1475, 2024 | | 2024 |
| Business Analytics Competition (BAC@ MC): A learning experience S Ammar, MJ Kim, AH Masoumi, A Tomoiaga Decision Sciences Journal of Innovative Education 21 (2), 52-67, 2023 | | 2023 |
| Genomic Big Data Regression Analysis A Tomoiaga, J Farelly, S Nakamura American Journal of Advanced Research 2, 1, 2018 | | 2018 |
| Statistical methods in genomic pathway analysis A Tomoiaga | | 2014 |
| Supplementary materials-analysis and correction of crosstalk effects in pathway analysis M Donato, Z Xu, A Tomoiaga, JG Granneman, RG MacKenzie, R Bao, ... Default journal, 2013 | | 2013 |
| Broad genic repression domains signify enhanced silencing of oncogenes G Wang, Q Meng, Y Yi, S Zhu, AS Tomoiaga, MG Lee, JP Cooke, Q Cao, ... | | |
| Clinical Trials Simulation System Documentation PH Westfall, K Tsai, M Dunn, S Ogenstad, A Tomoiaga, Y Lu, K Wang | | |
